52-week price history of ZYBT Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Zhengye Biotechnology Holding Ltd’s current trading price is -4.92% away from its 52-week high, while its distance from the 52-week low is 56.76%. The stock’s price range during this period has spanned from $3.70 to $6.10. In the Healthcare sector, the Zhengye Biotechnology Holding Ltd’s shares surpassed a trading volume of approximately 0.55 million for the day, which was noticeably higher compared to the average daily volume of 9.0.12 million over the past three months.
Making Sense of Trading Volume and Moving Average Data
Examining ZYBT’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ZYBT stands at 0.31. Similarly, the long-term debt-to-equity ratio is also 0.00.
ZYBT Stock Stochastic Average
Today, Zhengye Biotechnology Holding Ltd’s raw stochastic average for the past 50 days stands at 97.44%, indicating a rise from the raw stochastic average of the last 20 days, which was 97.31%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 66.66% and 58.49% respectively.
ZYBT Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 19.34% this year. The price of ZYBT fallen by 25.54% during the last 30 days period. For the last 5-days stocks have improved 25.27%.
